Y. Dong

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.

D. Harlan, A. Kirk, D. Thomas, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Risk factors for BK virus infection and BK virus-associated nephropathy under the impact of intensive monitoring and pre-emptive immunosuppression reduction.

Y. Dong, R. Deng, Gang Huang, 2014, Transplantation proceedings.

Immunosuppression with Belatacept‐Based, Corticosteroid‐Avoiding Regimens in De Novo Kidney Transplant Recipients

W. Marks, Y. Dong, E. Woodle, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9.

A. Kirk, N. Armstrong, Y. Dong, 1998, Transplantation.

Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients.

K. Nadeau, A. Kirk, Y. Dong, 2001, Transplantation.

Increased glomerular deposits of von Willebrand factor in chronic, but not acute, rejection of primate renal allografts.

Y. Dong, X. Hong, J. Fechner, 2000, Transplantation.

Inducing unresponsiveness by the use of anti-CD3 immunotoxin, CTLA4-Ig, and anti-CD40 ligand.

D. Harlan, A. Kirk, Y. Dong, 1999, Transplantation proceedings.

Activation of T lymphocytes for adhesion and cytokine expression by toxin-conjugated anti-CD3 monoclonal antibodies.

Y. Dong, M. Hamawy, M. Tsuchida, 1999, Transplantation.

Graft survival in a rhesus renal transplant model after immunotoxin-mediated T-cell depletion is enhanced by mycophenolate and steroids.

Y. Dong, X. Hong, J. Fechner, 2001, Transplantation.

Reversal of acute allograft rejection using immunotoxin.

Y. Dong, X. Hong, J. Fechner, 1998, Transplantation proceedings.

Primate renal transplants using immunotoxin.

N. Armstrong, Y. Dong, X. Hong, 1998, Surgery.

IMMUNOSUPPRESSION WITH BELATACEPT-BASED, CNI-AVOIDING AND STEROID-AVOIDING REGIMENS VS A TACROLIMUS-BASED, STEROID-AVOIDING REGIMEN IN KIDNEY TRANSPLANT PATIENTS: RESULTS OF A 1-YEAR, RANDOMIZED STUDY: 1436

W. Marks, Y. Dong, E. Woodle, 2010 .